Comprehensive Metabolic Panel Testing Market
Comprehensive Metabolic Panel Testing Market Forecasts to 2030 - Global Analysis By Test Type (Glucose, Calcium, Electrolytes, Kidney Function Tests, Liver Function Tests, Proteins and Other Test Types), Disease (Diabetes, Kidney Disease, Liver Disease and Other Diseases), End User (Point of Care Centers, Diagnostic Laboratories, Hospitals and Other End Users) and by Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $11.32 BN |
Projected Year Value (2030) |
US $23.65 BN |
CAGR (2023 - 2030) |
11.1% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Comprehensive Metabolic Panel Testing Market is accounted for $11.32 billion in 2023 and is expected to reach $23.65 billion by 2030 growing at a CAGR of 11.1% during the forecast period. A diagnostic blood test called a Comprehensive Metabolic Panel (CMP) offers a thorough assessment of a person's metabolic health. It assesses a number of markers linked to blood sugar, electrolyte balance, and organ function. Tests for glucose, electrolytes, and liver, kidney, and protein levels in the blood are commonly included in a CMP. Moreover, this panel helps identify and track diseases like diabetes, liver disease, and kidney dysfunction by providing insightful information about the general health of important organs like the liver and kidneys.
According to International Diabetes Federation (IDF), over 540 million people are suffering from diabetes worldwide, and by 2045 the numbers are expected to cross 780 million marks.
Market Dynamics:
Driver:
Increased frequency of metabolic illnesses
One major factor propelling the market for Comprehensive Metabolic Panel (CMP) testing is the rising prevalence of metabolic disorders worldwide, such as diabetes, obesity, and non-alcoholic fatty liver disease. Additionally, regular metabolic profiling is imperative to facilitate early detection, intervention, and efficient disease management, given the increasing prevalence of lifestyle factors and dietary patterns associated with these conditions.
Restraint:
Low level of education and awareness
Even with the growing focus on preventive healthcare, there is still a significant knowledge gap about the significance of full metabolic panel testing. The lack of awareness among healthcare professionals and the general public regarding the comprehensive range of data these tests offer and their significance in the early identification of illnesses impedes their use. Furthermore, in order to overcome this limitation, focused education campaigns that foster knowledge and proactive participation in metabolic health monitoring are required, aimed at both the general public and healthcare professionals.
Opportunity:
Targeted therapies and personalized medicine
There is a big chance for the market because of the growing emphasis on personalized medicine. The precision of treatment plans can be improved by combining metabolic panel data with individual genetic information as molecular diagnostics and genetic profiling continue to advance. Moreover, this makes it possible to develop targeted therapies that are suited to each patient's particular metabolic profile, enhancing treatment effectiveness and reducing side effects.
Threat:
Pricing pressure and the competitive environment
The CMP testing market is significantly threatened by the industry as well as pricing pressures. A pricing war amongst diagnostic companies could jeopardize the long-term viability of comprehensive metabolic panel testing services due to intense competition. Additionally, laboratories must use cost-cutting strategies, value-added services, and strategic differentiation to survive in this cutthroat market without sacrificing customer satisfaction.
Covid-19 Impact:
There are several ways in which the COVID-19 pandemic has affected the market. A brief drop in routine diagnostic testing, including CMP tests, was initially caused by disruptions in healthcare services, issues with the supply chain, and a change in healthcare priorities toward managing the pandemic. The significance of thorough metabolic assessments in determining the effects of COVID-19 on patients, particularly those with metabolic complications, was acknowledged more as the healthcare sector adjusted to the new normal. Furthermore, point-of-care testing, telemedicine, and digital health solutions have all seen rapid adoption as a result of the pandemic, which has changed the dynamics of the CMP testing market.
The Diabetes segment is expected to be the largest during the forecast period
Due to the fact that diabetes is a chronic condition with a high prevalence, it is expected to hold the largest share of the market. Diabetes is a metabolic disease that affects millions of people worldwide and is typified by elevated blood glucose levels. Moreover, a broad range of goods and services are available in the diabetes management market, such as prescription drugs, glucose monitors, insulin treatments, and lifestyle modifications. Significant investments have been made in research, development, and creative approaches to disease management as a result of the rising prevalence of diabetes, which is fueled by factors like sedentary lifestyles and poor dietary habits.
The Point of care Centers segment is expected to have the highest CAGR during the forecast period
The market's highest CAGR is being seen in the point-of-care centers segment. Point-of-care testing has become increasingly popular because of its ease of use, speed, and capacity to simplify the delivery of healthcare. It is typified by quick diagnostics and real-time results at or close to the patient. These facilities provide a broad range of diagnostic services, with results available in a matter of minutes. These services include blood tests, urinalysis, and other crucial assessments. Additionally, point-of-care center expansion has been driven by the growing emphasis on decentralizing healthcare services, increasing patient accessibility, and shortening diagnosis turnaround times.
Region with largest share:
The market for CMP testing is expected to have the largest share in the North American region. A large patient population with chronic metabolic conditions, a well-established healthcare infrastructure, and a high level of awareness regarding preventive healthcare are some of the factors contributing to the region's dominance. Furthermore, technology developments, the existence of major industry players, and advantageous reimbursement practices have all aided in the expansion of the CMP testing market in North America.
Region with highest CAGR:
The comprehensive metabolic panel (CMP) testing market is expected to grow at the highest CAGR in the Asia-Pacific region. A number of factors are driving the region's growth, such as a quickly growing population, growing healthcare awareness, and an increase in the prevalence of metabolic disorders. The Asia-Pacific region's burgeoning need for comprehensive metabolic panel testing is partly due to improved healthcare infrastructure and the uptake of cutting-edge diagnostic technologies. Moreover, the market in this region is expected to grow at a robust rate due to the increasing prevalence of lifestyle-related diseases and the growing emphasis on early detection and management.
Key players in the market
Some of the key players in Comprehensive Metabolic Panel Testing market include Charles River Laboratories Inc., Genoptix Inc., Baptist Health Medical Group, ARUP Laboratories, Scion Lab Services LLC, NeoGenomics Laboratories, Inc., Abbott Laboratories, Unipath, Siemens Healthcare GmbH, Nova Medical, CENTOGENE N.V., Quest Diagnostics Incorporated, Cleveland HeartLab, Inc., Sonic Healthcare, TCG Corp. and SYNLAB International GmbH.
Key Developments:
In December 2023, Charles River Laboratories International, Inc. announced an important milestone in their strategic collaboration to manufacture CASGEVY™. CASGEVY is approved in some countries for certain eligible patients. The news follows Charles River’s Memphis center of excellence passing back-to-back audits from both the U.S. Food and Drug Administration and the Health Products Regulatory Authority, on behalf of the European Medicines Agency.
In December 2023, Baptist Health Baptist Hospital launched the Inspiration Hall, powered by national leader in hospice and palliative care services, VITAS Healthcare. Located on the first floor near the hospital’s imaging center waiting room, the Inspiration Hall is an immersive experience where patients, visitors and hospital team members can submit, read or watch messages of comfort and support that will inspire others in their health journey.
In December 2023, A partnership between ARUP Laboratories and Medicover has made a new companion diagnostic, and thereby a new gene therapy, more accessible to patients in the European Union. ARUP Laboratories, in close collaboration with BioMarin Pharmaceutical Inc., developed AAV5 DetectCDx™, a companion diagnostic that aids in the selection of adult patients with severe hemophilia A who are eligible for treatment with ROCTAVIAN™, a new gene therapy developed by BioMarin.
Test Types Covered:
• Glucose
• Calcium
• Electrolytes
• Kidney Function Tests
• Liver Function Tests
• Proteins
• Other Test Types
Diseases Covered:
• Diabetes
• Kidney Disease
• Liver Disease
• Other Diseases
End Users Covered:
• Point of Care Centers
• Diagnostic Laboratories
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Comprehensive Metabolic Panel Testing Market, By Test Type
5.1 Introduction
5.2 Glucose
5.3 Calcium
5.4 Electrolytes
5.4.1 Sodium
5.4.2 Potassium
5.4.3 Other Electrolytes
5.5 Kidney Function Tests
5.5.1 Blood Urea Nitrogen (BUN)
5.5.2 Creatinine
5.6 Liver Function Tests
5.6.1 Albumin
5.6.2 Bilirubin
5.6.3 Alkaline Phosphatase
5.6.4 Aspartate Aminotransferase (AST)
5.6.5 Alanine Aminotransferase (ALT)
5.7 Proteins
5.8 Other Test Types
6 Global Comprehensive Metabolic Panel Testing Market, By Disease
6.1 Introduction
6.2 Diabetes
6.3 Kidney Disease
6.4 Liver Disease
6.5 Other Diseases
7 Global Comprehensive Metabolic Panel Testing Market, By End User
7.1 Introduction
7.2 Point of Care Centers
7.3 Diagnostic Laboratories
7.4 Hospitals
7.5 Other End Users
8 Global Comprehensive Metabolic Panel Testing Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Charles River Laboratories Inc.
10.2 Genoptix Inc.
10.3 Baptist Health Medical Group
10.4 ARUP Laboratories
10.5 Scion Lab Services LLC
10.6 NeoGenomics Laboratories, Inc.
10.7 Abbott Laboratories
10.8 Unipath
10.9 Siemens HealthCare GmbH
10.10 Nova Medical
10.11 CENTOGENE N.V.
10.12 Quest Diagnostics Incorporated
10.13 Cleveland HeartLab, Inc.
10.14 Sonic HealthCare
10.15 TCG Corp.
10.16 SYNLAB International GmbH
List of Tables
1 Global Comprehensive Metabolic Panel Testing Market Outlook, By Region (2021-2030) ($MN)
2 Global Comprehensive Metabolic Panel Testing Market Outlook, By Test Type (2021-2030) ($MN)
3 Global Comprehensive Metabolic Panel Testing Market Outlook, By Glucose (2021-2030) ($MN)
4 Global Comprehensive Metabolic Panel Testing Market Outlook, By Calcium (2021-2030) ($MN)
5 Global Comprehensive Metabolic Panel Testing Market Outlook, By Electrolytes (2021-2030) ($MN)
6 Global Comprehensive Metabolic Panel Testing Market Outlook, By Sodium (2021-2030) ($MN)
7 Global Comprehensive Metabolic Panel Testing Market Outlook, By Potassium (2021-2030) ($MN)
8 Global Comprehensive Metabolic Panel Testing Market Outlook, By Other Electrolytes (2021-2030) ($MN)
9 Global Comprehensive Metabolic Panel Testing Market Outlook, By Kidney Function Tests (2021-2030) ($MN)
10 Global Comprehensive Metabolic Panel Testing Market Outlook, By Blood Urea Nitrogen (BUN) (2021-2030) ($MN)
11 Global Comprehensive Metabolic Panel Testing Market Outlook, By Creatinine (2021-2030) ($MN)
12 Global Comprehensive Metabolic Panel Testing Market Outlook, By Liver Function Tests (2021-2030) ($MN)
13 Global Comprehensive Metabolic Panel Testing Market Outlook, By Albumin (2021-2030) ($MN)
14 Global Comprehensive Metabolic Panel Testing Market Outlook, By Bilirubin (2021-2030) ($MN)
15 Global Comprehensive Metabolic Panel Testing Market Outlook, By Alkaline Phosphatase (2021-2030) ($MN)
16 Global Comprehensive Metabolic Panel Testing Market Outlook, By Aspartate Aminotransferase (AST) (2021-2030) ($MN)
17 Global Comprehensive Metabolic Panel Testing Market Outlook, By Alanine Aminotransferase (ALT) (2021-2030) ($MN)
18 Global Comprehensive Metabolic Panel Testing Market Outlook, By Proteins (2021-2030) ($MN)
19 Global Comprehensive Metabolic Panel Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
20 Global Comprehensive Metabolic Panel Testing Market Outlook, By Disease (2021-2030) ($MN)
21 Global Comprehensive Metabolic Panel Testing Market Outlook, By Diabetes (2021-2030) ($MN)
22 Global Comprehensive Metabolic Panel Testing Market Outlook, By Kidney Disease (2021-2030) ($MN)
23 Global Comprehensive Metabolic Panel Testing Market Outlook, By Liver Disease (2021-2030) ($MN)
24 Global Comprehensive Metabolic Panel Testing Market Outlook, By Other Diseases (2021-2030) ($MN)
25 Global Comprehensive Metabolic Panel Testing Market Outlook, By End User (2021-2030) ($MN)
26 Global Comprehensive Metabolic Panel Testing Market Outlook, By Point of Care Centers (2021-2030) ($MN)
27 Global Comprehensive Metabolic Panel Testing Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
28 Global Comprehensive Metabolic Panel Testing Market Outlook, By Hospitals (2021-2030) ($MN)
29 Global Comprehensive Metabolic Panel Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.